Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01255748
Previous Study | Return to List | Next Study

Registry Study for Radiation Therapy Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01255748
Recruitment Status : Recruiting
First Posted : December 7, 2010
Last Update Posted : April 3, 2020
Sponsor:
Information provided by (Responsible Party):
Proton Collaborative Group

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Condition or disease Intervention/treatment
Solid Tumors Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 20000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 30 Years
Official Title: Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy
Study Start Date : June 2009
Estimated Primary Completion Date : June 2029
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Treatment with Radiation Therapy
Includes 9 different arms to capture patient data by disease site
 Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Define outcomes for patients treated at participating institutions [ Time Frame: PRN ]

Secondary Outcome Measures :
  1. Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures [ Time Frame: Annually PRN ]
  2. Improve patient care by an adequate understanding of the results and patient population at participating institutions [ Time Frame: Reviewed Annually PRN ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Radiation Oncology patients
Criteria

Inclusion Criteria:

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01255748


Contacts
Layout table for location contacts
Contact: Tish Adams, MS, CCRC, CP 913-788-6429 tadams@pcgresearch.org
Contact: Matthew Morocco, BS 630-836-8670 mmorocco@pcgresearch.org

Locations
Layout table for location information
United States, Arizona
Mayo Clinic Recruiting
Scottsdale, Arizona, United States, 85259-5499
Contact: Clinical Trials Office - All Mayo Clinic Locations    855-776-0015 (toll free)      
United States, California
California Protons Cancer Therapy Center Recruiting
San Diego, California, United States, 92121
Contact: Alex Hollihan, MPH    858-549-7431    Alexandra.Hollihan@californiaprotons.com   
Principal Investigator: James Urbanic, MD         
United States, Florida
Miami Cancer Institute Recruiting
Miami, Florida, United States, 33176
Contact: Alex Kudryashev    786-596-2000    alexku@baptisthealth.net   
Principal Investigator: Michael Chuong, MD         
United States, Illinois
Northwestern Medicine Chicago Proton Center Recruiting
Warrenville, Illinois, United States, 60555
Contact: Karen Brown    630-315-1797    Karen.Brown@nm.org   
Principal Investigator: William Hartsell, MD         
United States, Louisiana
Willis-Knighton Cancer and Proton Therapy Center Recruiting
Shreveport, Louisiana, United States, 71103
Contact: Briana Barrow, CCRC    318-212-8671    bbarrow@wkhs.com   
Principal Investigator: L. Ben Wilkinson, MD         
United States, Maryland
Maryland Proton Treatment Center Recruiting
Baltimore, Maryland, United States, 21201
Contact: Carl Brown    410-369-5353    CarlBrown@umm.edu   
Principal Investigator: Shahed Badiyan, MD         
United States, Michigan
Beaumont Health Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Joanne Gondert, RN    248-551-0439    Joanne.Gondert@Beaumont.org   
Principal Investigator: Craig Stevens, MD         
United States, New Jersey
ProCure Proton Therapy Center Recruiting
Somerset, New Jersey, United States, 08873
Contact: Heba Darwish    732-357-2676    Heba.Darwish@nj.procure.com   
Principal Investigator: Henry Tsai, MD         
United States, New York
New York Proton Center Recruiting
New York, New York, United States, 10035
Contact: Elodie Benard, MS, CCRP    646-968-9060 ext 378    ebenard@nyproton.com   
Principal Investigator: Charles Simone, MD, FACRO         
United States, Oklahoma
ProCure Proton Therapy Center Recruiting
Oklahoma City, Oklahoma, United States, 73142
Contact: Kayla Tarrant    405-773-6775    research@okc.procure.com   
Principal Investigator: Gary Larson, MD         
United States, Virginia
Inova Schar Cancer Institute Recruiting
Fairfax, Virginia, United States, 22031
Contact: Annicole Buranych    571-472-4724    Annicole.Buranych@inova.org   
Principal Investigator: Gopal K Bajaj, MD         
Hampton University Proton Therapy Institute Recruiting
Hampton, Virginia, United States, 23666
Contact: Donna Sternberg, RN, BSN, OCN    757-251-6839    Donna.Sternberg@hamptonproton.org   
Principal Investigator: Christopher Sinesi, MD         
United States, Washington
University of Washington Recruiting
Seattle, Washington, United States, 98195-6043
Contact: Emily Wing    206-598-8629    Emilyrw5@uw.edu   
Principal Investigator: George Laramore, MD         
Sponsors and Collaborators
Proton Collaborative Group
Investigators
Layout table for investigator information
Study Chair: Carlos Vargas, MD Proton Collaborative Group
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Proton Collaborative Group
ClinicalTrials.gov Identifier: NCT01255748    
Other Study ID Numbers: REG001-09
First Posted: December 7, 2010    Key Record Dates
Last Update Posted: April 3, 2020
Last Verified: July 2019
Keywords provided by Proton Collaborative Group:
cancer, proton, radiation